Filing Details
- Accession Number:
- 0001181431-11-015611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-04 14:47:19
- Reporting Period:
- 2011-03-02
- Filing Date:
- 2011-03-04
- Accepted Time:
- 2011-03-04 14:47:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-03-02 | 55,237 | $76.38 | 6,065,987 | No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| Common Stock | Disposition | 2011-03-02 | 22,664 | $76.96 | 6,043,323 | No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| Common Stock | Disposition | 2011-03-03 | 16,869 | $77.20 | 6,026,454 | No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| Common Stock | Disposition | 2011-03-03 | 5,230 | $77.55 | 6,021,224 | No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd |
| No | 4 | S | Indirect | By Nichsei Arkin Ltd |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,130 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $75.575 to $76.57. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $76.58 to $77.39. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $76.50 to $77.50. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $77.51 to $77.64. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
Billionaire Hedge Funds
